THE CHOICE OF PROTECTIVE POLYMER COATING FOR THE L-ARGININE WITH THIOTRIAZOLINE CORE TABLETS
DOI:
https://doi.org/10.11603/2312-0967.2019.2.9927Keywords:
L-arginin, stroke, tablets, thiotriazoline, film coatingAbstract
The aim of the work. The choice a protective polymer film-forming system for coating of L-arginine with thiotriazoline core tablets.
Materials and methods. In the course of work for the production of core tablets, thiotriazolin, L-arginine and registered excipients were used. The core tablets were prepared by the wet granulation method in laboratory conditions at the Pharmaceutical Chemistry Department of the ZSMU. The film-forming compositions of the Opadry brand in various concentrations, the Glatt apparatus for applying the film-forming coating were used; the volume of the drum was 0,8L at 400 g of loading mass. 3% of the film-forming agent was applied to the core tablets.
Results and discussion. According to the fact that the film-forming coatings at the same concentration provide different viscosity, the recommended by Colorcon manufacturer were used for the experiment: 15% suspension for coating with HPMC, 20% and 30% suspension for PVD coating. Each series of obtained tablets was evaluated in: appearance, uniformity of mass, resistance to crushing, disintegration. The dispersion analysis of the experimental data of the coated L-arginine with thiotriazolin tablets showed, that OPADRY is the best of the five types of film-forming systems.
Conclusion: Conducted research on the choice of film-forming system for coating of core L-arginine with thiotriazoline tablets by protective polymeric film. According to the obtained indicators - the appearance of the film, the uniformity of coated tablets mass, their resistance to crushing and the disintegration, it is rational to use the15% film-forming OPADRY suspension.
References
Mazur IA, Chekman IS, Belenichev IF. Metabolithotropic drugs. [Метаболитотропные препараты] Zaporozhye; 2007. Russian.
Mazur IA, Voloshyn NA, Chekman IS. [Thiotriazoline: pharmacological aspects and clinical usage]. Novyny medytsyny i farmatsii. 2005; 160. Ukrainian.
Mazur IA, Chekman IS, Belenichev IF, Kucherenko LI. [The development of medicines based on fixed combinations with antioxidants is a promising area of modern pharmacology]. Farmakol ta likar toksykol. 2011;5: 199-00. Russian.
Kucherenko L, Belenichev I, Mazur I, Khromylova O. Methabolithotropic aspects of cardioprotective action of new combined medicine based on L-Arginine and Thiotriazolin at modeling of myocardial infarction. Asian J Pharm Clin Res 2017;10 (10): 158-61. DOI: https://doi.org/10.22159/ajpcr.2017.v10i10.19895
Mazur ІА, Kucherenko LА, Belenichev IА, Khromylova OV, Siusiuka VH. inventors; RPA "Farmatron", assignee. Комбінований лікарський засіб гепатопротекторної, кардіопротекторної, плацентопротективної, токолітичної і NO-міметичної дії [Combination Drug with Hepatoprotective, Cardioprotective, Placentoprotective, Tocolytic and NO-Mimetic Action]. UA 110597. 2016 Jan 01. Ukrainian.
Khromylova OV. [Selection of excipients for L-arginine tablets with thiotriazoline by wet granulation (Report 1)]. Retsept. 2018;4(21): 516-24. Russian.
Khromylova OV. [Selection of excipients for L-arginine tablets with thiotriazoline by wet granulation]. Farmatsevt chasop. 2018;4(48): 35-41. DOI https://doi.org/10.11603/2312-0967.2018.4.9704 DOI: https://doi.org/10.11603/2312-0967.2018.4.9704
State Pharmacopoeia of Ukraine: in 3 vol. [Державна Фармакопея України: в 3 т.] State Enterprise Ukrainian Scientific Pharmacopoeial Center of Medicines Quality. - 2nd edn. Kharkiv: State Enterprise Ukrainian Scientific Pharmacopoeial Center of Medicines Quality, 2015. Ukrainian.
Hroshovyi TA, Martseniuk VP, Kucherenko LI, Vronska LV, Hurieieva SM. Matematychne planuvannia eksperymentu v farmatsii [Mathematical planning of experiment in pharmacy]. Ternopil: Ternopil State Medical University; 2008. Ukrainian.
Downloads
Published
How to Cite
Issue
Section
License
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal .
- Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).